Global Orodispersible Film Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Orodispersible Film Market Research Report 2024
Orodispersible film (ODF) is a new oral pharmaceutical form, whose characteristics are able to improve the treatment compliance of certain groups of subjects whose needs are not met by capsules and tablets. They take the form of small, thin, flexible sheets, similar to postage stamps that, when placed inside the mouth, dissolve rapidly in contact with saliva. The dissolution time is usually a few dozen seconds and in any case no more than one minute. The weight of a single film is usually a few hundred mg, meaning that very little saliva is required for dissolution.
According to Mr Accuracy reports’s new survey, global Orodispersible Film market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Orodispersible Film market research.
Key manufacturers engaged in the Orodispersible Film industry include Aquestive Therapeutics, Kyukyu Pharmaceutical, Tapemark, Shilpa Therapeutics, BioDelivery(BDSI), IntelGenx, CL Pharm, Lubrizol Life Science and Adhex Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Orodispersible Film were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Orodispersible Film market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Orodispersible Film market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Aquestive Therapeutics
Kyukyu Pharmaceutical
Tapemark
Shilpa Therapeutics
BioDelivery(BDSI)
IntelGenx
CL Pharm
Lubrizol Life Science
Adhex Pharma
DK Livkon
Arx Pharma
Aavishkar
ZIM Laboratories
Umang Pharmaceuticals
Cure Pharmaceutical
Segment by Type
Natural Polymer
Synthetic Polymer
Hospital and Clinic
Drug Store
E-commerce
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Orodispersible Film report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Orodispersible Film market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Orodispersible Film market research.
Key manufacturers engaged in the Orodispersible Film industry include Aquestive Therapeutics, Kyukyu Pharmaceutical, Tapemark, Shilpa Therapeutics, BioDelivery(BDSI), IntelGenx, CL Pharm, Lubrizol Life Science and Adhex Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Orodispersible Film were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Orodispersible Film market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Orodispersible Film market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Aquestive Therapeutics
Kyukyu Pharmaceutical
Tapemark
Shilpa Therapeutics
BioDelivery(BDSI)
IntelGenx
CL Pharm
Lubrizol Life Science
Adhex Pharma
DK Livkon
Arx Pharma
Aavishkar
ZIM Laboratories
Umang Pharmaceuticals
Cure Pharmaceutical
Segment by Type
Natural Polymer
Synthetic Polymer
Segment by Application
Hospital and Clinic
Drug Store
E-commerce
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Orodispersible Film report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source